ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,951 | -74.2% | 75,500 | 0.0% | 0.00% | -66.7% |
| Q2 2023 | $38,505 | -19.0% | 75,500 | 0.0% | 0.01% | -25.0% |
| Q1 2023 | $47,565 | +3.9% | 75,500 | +7.1% | 0.01% | +9.1% |
| Q4 2022 | $45,762 | -66.4% | 70,500 | -10.8% | 0.01% | -68.6% |
| Q3 2022 | $136,000 | +43.2% | 79,050 | +3.3% | 0.04% | +45.8% |
| Q2 2022 | $95,000 | +35.7% | 76,550 | +19.5% | 0.02% | +41.2% |
| Q4 2021 | $70,000 | +12.9% | 64,050 | +87.0% | 0.02% | +6.2% |
| Q3 2021 | $62,000 | -31.1% | 34,250 | 0.0% | 0.02% | -36.0% |
| Q2 2021 | $90,000 | +3.4% | 34,250 | +41.2% | 0.02% | -3.8% |
| Q1 2021 | $87,000 | +42.6% | 24,250 | 0.0% | 0.03% | +30.0% |
| Q4 2020 | $61,000 | 0.0% | 24,250 | 0.0% | 0.02% | -9.1% |
| Q3 2020 | $61,000 | -23.8% | 24,250 | 0.0% | 0.02% | -29.0% |
| Q2 2020 | $80,000 | +35.6% | 24,250 | 0.0% | 0.03% | +19.2% |
| Q1 2020 | $59,000 | -48.2% | 24,250 | 0.0% | 0.03% | -45.8% |
| Q4 2019 | $114,000 | – | 24,250 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 12,546,493 | $22,835,000 | 1.71% |
| MSD Partners, L.P. | 15,151,516 | $27,576,000 | 0.84% |
| MSD Partners, L.P. | 7,575,758 | $13,788,000 | 0.42% |
| CHIRON CAPITAL MANAGEMENT, LLC | 198,002 | $360,000 | 0.26% |
| Avidity Partners Management LP | 3,000,000 | $5,460,000 | 0.12% |
| Old West Investment Management, LLC | 211,513 | $384,000 | 0.10% |
| MAGNOLIA CAPITAL ADVISORS LLC | 103,239 | $188,000 | 0.07% |
| Virtus ETF Advisers LLC | 72,060 | $131,000 | 0.06% |
| ACT WEALTH MANAGEMENT, LLC | 34,454 | $91,000 | 0.06% |
| Allred Capital Management, LLC | 53,000 | $96,000 | 0.05% |